Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 6Other hematologic neoplasm 2Myeloid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27Leukemia, Myeloid, Chronic-Phase 9Leukemia 5Philadelphia Chromosome 4Blast Crisis 4Bronchiolitis Obliterans Syndrome 3Leukemia, Myeloid, Accelerated Phase 2Leukemia, Myeloid 2Breast Neoplasms 2Translocation, Genetic 1Pathologic Processes 1Neoplasms by Histologic Type 1Neoplasms 1Myeloproliferative Disorders 1Leukemia, Myeloid, Acute 1Hematologic Diseases 1Bone Marrow Diseases 1

Interventions

Cyclophosphamide 7Therapeutics 6Flow Cytometry 6Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Filgrastim 4Psychiatric Rehabilitation 3Polymerase Chain Reaction 3Paclitaxel 3Immunologic Techniques 3Immunoenzyme Techniques 3Doxorubicin 3Carboplatin 3Amplified Fragment Length Polymorphism Analysis 3venetoclax 2trametinib 2temsirolimus 2sargramostim 2ruxolitinib 2pertuzumab 2pembrolizumab 2palbociclib 2liposomal doxorubicin 2liposomal amphotericin B 2dabrafenib 2copanlisib 2bosutinib 2aldesleukin 2abiraterone 2Vorinostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × bosutinib × Other hematologic neoplasm × Clear all
NCT00759837 2009-07-16

Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects

Wyeth is now a wholly owned subsidiary of Pfizer

Phase 1 Completed
27 enrolled
BreastMyeloidOther hematologic neoplasm

Breast Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00777530 2008-10-23

Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects

Wyeth is now a wholly owned subsidiary of Pfizer

Phase 1 Completed
48 enrolled
BreastOther hematologic neoplasm

Breast Neoplasms, Leukemia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡